| Ytd | 79.71% | |
| 1y | 226.67% |
| Open | Prev Close | 7.35 | Low | 7.30 | High | 7.37 | Mkt Cap | 2.73B | |
| Vol | 0.00 | Avg Vol | 15.02M | EPS | -2.79 | P/E | N/A | Forward P/E | -15.31 |
| Beta | 1.55 | Short Ratio | 2.84 | Inst. Own | 52.30% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 6.90 | 200-d Avg | 4.74 | 1yr Est | 8.12 |
ATAI News
AtaiBeckley Inc (ATAI) reported earnings 30 days ago. What's next for the stock?
Lilly is expanding its neuroscience pipeline through strong growth and M&A, aiming to build a new lo
On CNBC's “Mad Money Lightning Round,” Jim Cramer said he is not sure that there's a lot of upside i
Cramer favors Howmet, remains cautious on AeroVironment, Rocket, AtaiBeckley and MP Materials, citin
As previously disclosed, AtaiBeckley Inc. (the "Company") entered into an Agreement and Plan
AtaiBeckley Investor Alert: Kahn Swick and Foti, LLC Investigates Adequacy of Price and Process in P
NEW YORK CITY and NEW ORLEANS, Aug. 28, 2026 /PRNewswire/ -- Former Attorney General of Louisiana Ch
Are DSGR, HLX, ATAI, CRNX Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Aug. 17
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of [url="]Kahn Swic
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,
Analysts changed outlooks on top stocks. Raymond James downgraded ONON, Deutsche Bank downgraded ATA
Wall Street analysts change outlook on top names. HC Wainwright raises price target for Belite Bio,
The mean of analysts' price targets for AtaiBeckley Inc (ATAI) points to a 31.5% upside in the stock
Jim Cramer praises Lockheed Martin and Ameriprise Financial, advises against Cipher Digital. Eli Lil
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
One of Cathie Wood's funds just sold some AtaiBeckley shares. It also bought some Compass Pathways s
MONSEY, N.Y., July 28, 2026 (GLOBE NEWSWIRE) -- The Monsey law firm of Wohl & Fruchter LLP is invest
Lilly's purchase of AtaiBeckley is yet another strategic move in its bid to diversify its pipeline.
The consensus price target hints at a 33.3% upside potential for AtaiBeckley Inc (ATAI). While empir
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,
Lulu's Fashion Lounge Holdings (NASDAQ:LVLU) retained Solomon Partners as its financial advisor and
Deal Dispatch features companies for sale or bought — also off the block — and what bankruptcies are
LLY agrees to acquire AtaiBeckley for $2.8B upfront to expand its neuroscience pipeline with psyched
Top Wall Street analysts changed outlook on top names. Check full changes on analyst ratings page. O
Compass Pathways (NASDAQ:CMPS)'s COMP360 treatment model may face fewer regulatory hurdles as new Ph
Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.6% to $0.18 during Thursday's
GH Research and Definium Therapeutics stocks rose after Eli Lilly agreed to buy AtaiBeckley in a dea
U.S. stocks mixed, Nasdaq falls 150 points. Abbott Labs beats Q2 estimates and raises guidance, sto
U.S. stock futures declined on Thursday, as the Dow Jones, Nasdaq 100, and S&P 500 indices fell,
Gainers AtaiBeckley (NASDAQ:ATAI) stock rose 34.3% to $7.2 during Thursday's pre-market session
JB Hunt Transport Services Inc (JBHT) beat earnings and revenue estimates, causing shares to surge 7
Health officials explored restricting specific antidepressants among SSRI drugs-sources
https://www.hhs.gov/press-room/fda-accelerates-action-treatments-serious-mental-illness-following-ex
Nektar Therapeutics (NASDAQ: NKTR) rose on positive results for alopecia treatment. Other top gainer
Psychedelic drug maker shares jumped in Monday pre-market after an order from President Donald Trump
TopBuild Corp (NYSE: BLD) rises in pre-market trading after QXO (NYSE: QXO) agrees to acquire for $1
Top Wall Street analysts changed outlook on top names; Benchmark raised JBHT's price target; Tru
https://www.cbsnews.com/news/psychedelic-drug-ibogaine-ptsd-trump-to-sign-executive-order/
https://www.marijuanamoment.net/bipartisan-senators-file-bill-to-support-psychedelics-research-and-t
Helus Pharma (Cybin) shares fall after Phase 2 anxiety drug results show symptom improvement, but pr
The FDA lifted its clinical hold on GH Research's GH001 after Phase 2b data showed rapid, durabl
On Thursday, Cathie Wood-led Ark Invest executed significant trades, notably selling shares of Tempu
U.S. stock futures rose on Monday after ending higher on Friday. Futures of major benchmark indices
